PLPC vs. PRAX
PLPC (Preformed Line Products Company) and PRAX (Praxis Precision Medicines, Inc.) are both stocks. PLPC operates in Electrical Equipment & Parts (Industrials), while PRAX operates in Biotechnology (Healthcare). Over the past 5 years, PLPC returned 38.79%/yr vs -0.71%/yr for PRAX. At a 0.13 correlation, their price movements are largely independent.
Performance
PLPC vs. PRAX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PLPC achieves a 83.26% return, which is significantly higher than PRAX's -5.36% return.
PLPC
- 1D
- -2.47%
- 1M
- 22.08%
- YTD
- 83.26%
- 6M
- 76.73%
- 1Y
- 169.97%
- 3Y*
- 36.16%
- 5Y*
- 38.79%
- 10Y*
- 25.67%
PRAX
- 1D
- 8.08%
- 1M
- -17.38%
- YTD
- -5.36%
- 6M
- 49.84%
- 1Y
- 577.01%
- 3Y*
- 164.05%
- 5Y*
- -0.71%
- 10Y*
- —
PLPC vs. PRAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PLPC Preformed Line Products Company | 83.26% | 62.61% | -3.93% | 61.77% | 29.93% | -4.34% | 32.41% |
PRAX Praxis Precision Medicines, Inc. | -5.36% | 282.98% | 245.42% | -37.59% | -87.92% | -64.19% | 97.91% |
Correlation
The correlation between PLPC and PRAX is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2020 | 0.13 |
Fundamentals
PLPC:
$1.86B
PRAX:
$8.06B
PLPC:
$6.94
PRAX:
-$13.77
PLPC:
3.93
PRAX:
5.71
PLPC:
$697.08M
PRAX:
-$92.00K
PLPC:
$215.09M
PRAX:
-$128.83M
PLPC:
$62.69M
PRAX:
-$344.68M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PLPC vs. PRAX — Risk / Return Rank
PLPC
PRAX
PLPC vs. PRAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Preformed Line Products Company (PLPC) and Praxis Precision Medicines, Inc. (PRAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PLPC | PRAX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.52 | ||
| Sortino ratioReturn per unit of downside risk | -2.90 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.86 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | 7.66 | 16.02 | -8.36 |
| Martin ratioReturn relative to average drawdown | 23.10 | 50.51 | -27.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PLPC | PRAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.45 | 2.93 | +0.52 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.89 | -0.01 | +0.89 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.58 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | -0.06 | +0.36 |
Drawdowns
PLPC vs. PRAX - Drawdown Comparison
The maximum PLPC drawdown since its inception was -66.36%, smaller than the maximum PRAX drawdown of -98.67%. Use the drawdown chart below to compare losses from any high point for PLPC and PRAX.
Loading charts...
Drawdown Indicators
| PLPC | PRAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.36% | -98.67% | +32.31% |
Max Drawdown (1Y)Largest decline over 1 year | -22.33% | -36.33% | +14.00% |
Max Drawdown (3Y)Largest decline over 3 years | -39.35% | -68.64% | +29.29% |
Max Drawdown (5Y)Largest decline over 5 years | -39.35% | -96.50% | +57.15% |
Max Drawdown (10Y)Largest decline over 10 years | -59.49% | — | — |
Current DrawdownCurrent decline from peak | -2.47% | -69.11% | +66.64% |
Average DrawdownAverage peak-to-trough decline | -24.84% | -80.66% | +55.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.39% | 11.50% | -4.11% |
Volatility
PLPC vs. PRAX - Volatility Comparison
The current volatility for Preformed Line Products Company (PLPC) is 19.47%, while Praxis Precision Medicines, Inc. (PRAX) has a volatility of 30.10%. This indicates that PLPC experiences smaller price fluctuations and is considered to be less risky than PRAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PLPC | PRAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.47% | 30.10% | -10.63% |
Volatility (6M)Calculated over the trailing 6-month period | 38.38% | 54.82% | -16.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.58% | 198.58% | -149.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.01% | 127.54% | -83.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.22% | 124.23% | -80.01% |
Dividends
PLPC vs. PRAX - Dividend Comparison
PLPC's dividend yield for the trailing twelve months is around 0.22%, while PRAX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PLPC Preformed Line Products Company | 0.22% | 0.39% | 0.63% | 0.60% | 0.72% | 1.24% | 1.17% | 1.33% | 1.47% | 1.13% | 1.38% | 1.90% |
PRAX Praxis Precision Medicines, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
PLPC vs. PRAX - Financials Comparison
This section allows you to compare key financial metrics between Preformed Line Products Company and Praxis Precision Medicines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PLPC and PRAX have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRAX has higher volatility (30.10%) compared to PLPC (19.47%). In terms of maximum drawdown, PLPC dropped -66.36% vs PRAX's -98.67%.
PLPC currently has the higher Sharpe Ratio (3.45 vs 2.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PLPC and PRAX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer